Fanny A. Pelissier Vatter

University of Bergen

Papers

1

Total Citations

25

H-Index

1

About

Fanny A. Pelissier Vatter is a cancer biologist whose work illuminates how the tumor microenvironment drives drug resistance and epithelial plasticity. Her research centers on the non-genetic mechanisms that allow cancer cells to evade therapy, with a particular focus on receptor tyrosine kinases like AXL and cKIT. In her highly cited 2018 study (25 citations), she demonstrated that specific microenvironments can impose non-sporadic expression of these receptors, challenging the prevailing view that drug-tolerant cells arise purely through stochastic epigenetic events. This work provides a mechanistic framework for understanding how spatial cues within tumors can systematically induce a plastic, drug-resistant state. Pelissier Vatter’s contributions are significant for their potential to identify microenvironmental vulnerabilities that could be targeted to prevent or reverse acquired resistance. Her findings have implications for combination therapy strategies, particularly in cancers where AXL and cKIT signaling are implicated in metastatic progression and treatment failure.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance
25 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Bergen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago